After sartans and ranitidine, where will NDMA show up next?
While regulators and pharma companies try to understand if it is the product or the process that is at fault in the ranitidine…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Apotex
Lupin Appoints Johnny Mikell as Global Head of Quality
Johnny will be based out of Lupin’s US offices and will lead the Company’s Quality function globally
Strides announces final closure of Arrow transaction
According to the statement filed by the company with BSE, all proceeds net of transaction cost will be used to pare down debt
Meda Pharmaceuticals and Cipla sue Apotex to enforce Dymista patents
Meda holds the NDA to manufacture and market Dymista in the US for the treatment of seasonal allergic rhinitis